As large biopharma companies have increasingly turned to China for novel biotech innovation, political calls in the U.S. to ...

Once the go-to location for global drugmakers, Europe is losing market share to aggressive U.S. trade policies and China's growth as a biotech hub. Europe's share of global R&D has been cut in half ...

Insider buying matters in every industry, but it carries a special weight in biotechnology. In most businesses, management has a reasonably clear view of sales trends, margins, customer demand, and ...